| 摘要 |
The present invention provides a use of chlorogenic acid in manufacturing medicaments for treating oligodendroglioma. The chlorogenic acid can inhibit oligodendroglioma and the growth of brain tumor stem cells, partially substitute radiotherapy and chemotherapy, and relieve the uncomfortable response of a patient caused by radiotherapy and chemotherapy. |
